Crescent Gene
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $60M
Investors
- 4
About Crescent Gene
Based in China, Crescent Gene operates as a biopharmaceutical technology company that provides solid tumor cell therapy products enable to enhance the treatment process of tumor patients.
Who invested in Crescent Gene
4 investors across 1 round
See all investors in Crescent Gene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 5, 2022
Amount
$60M
Investors
Questions about Crescent Gene
Who invested in Crescent Gene?
Crescent Gene has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Crescent Gene raised?
Crescent Gene has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Crescent Gene last raise money?
Crescent Gene's most recent round on record is a Series B, in Jan 2022.
What does Crescent Gene do?
Based in China, Crescent Gene operates as a biopharmaceutical technology company that provides solid tumor cell therapy products enable to enhance the treatment process of tumor patients.
Where is Crescent Gene headquartered?
Crescent Gene is headquartered in China.
Which VCs invest in companies like Crescent Gene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Crescent Gene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Crescent Gene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.